| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $380K | — | +3.0% |
| Cost of Revenue | $236K | — | -4.1% |
| Gross Profit | $144K | — | +17.1% |
| R&D Expense | $364K | — | -67.4% |
| SG&A Expense | $2.5M | — | +118.5% |
| Operating Income | -$3.2M | — | -34.6% |
| Pre-tax Income | -$2.8M | — | -23.1% |
| Net Income | -$2.8M | — | -23.1% |
| EPS (Basic) | -$0.70 | — | +45.7% |
| EPS (Diluted) | -$0.70 | — | +45.7% |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $1.9M | -54.4% | -70.9% |
| Accounts Receivable | $364K | +104.5% | +275.3% |
| Inventory | $1.4M | +69.0% | +228.0% |
| Current Assets | $4.3M | -23.5% | -43.2% |
| Total Assets | $7.8M | -17.8% | -31.8% |
| Current Liabilities | $4.2M | +11.8% |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | -$2.5M | — | -91.5% |
| Capital Expenditures | $7K | — | -88.1% |
| Investing Cash Flow | -$7K | — | +88.9% |
| Financing Cash Flow | $247K | — | -94.2% |
| Free Cash Flow | -$2.5M | — | -83.7% |
| +88.7% |
| Total Liabilities | $6.9M | +5.0% | +28.9% |
| Stockholders' Equity | $904K | -69.1% | -85.2% |